CHAIR
:
SPEAKER
(S):
Christopher Fuglesang, PhD, JD, Attorney , Tavistock Life Sciences
Frank Kung, Managing General Partner , Vivo Ventures, LLC
James Li, MD, Partner , Kleiner, Perkins Caufield & Byers
Greg Scott, Chief Executive Officer , ChinaBio Accelerator
Zhi Yang, PhD, General Partner , BioVeda Capital
Description
A panel of senior investors from top U.S. venture capital firms will discuss their deep experience and passion for investing in Asian companies. The open discussion will cover successes and failures, best practices and "hard lessons learned" on the way to bridging geographies, cultures and businesses. The speakers will share specific key success factors for fundraising strategies and tactics.
Objective1: Describe the challenges faced by Asian companies looking to raise capital from U.S. venture capital firms.
Objective2: Cover a best practices case study for the board room of Asian companies with U.S. investors.
Objective3: Discuss world-wide efforts to develop biotechnology "hubs."